Obstructive uropathy


Cite item

Full Text

Abstract

References

  1. Переверзев А. С. Обструктивная уронефропатия у детей. В кн.: Материалы трудов VIII Международного конгресса урологов "Актуальные проблемы детской урологии". Харьков; 2000. 3-28.
  2. Watson A. R. Urinary tract infection in early childhood. J. Antimicrob. Chemother. 1994; 34 (suppl. A): 53-60.
  3. Strutz F., Neilson E. G. The role of lymphocytes in the progression of interstitial disease. Kidney Int. 1994; 45 (suppl.): S106- SI 10.
  4. Eddy A. A. Molecular basis of renal fibrosis. Pediatr. Nephrol. 2000; 15 (3-4): 290-301.
  5. Brenner B. M., Mackenzie H. S. Nephron mass as a risk factor for progression of renal disease. Kidney Int. 1997; 53 (suppl.): S124-S127.
  6. Klahr S. Obstructive nephropathy. Kidney Int. 1998; 54: 286- 300.
  7. Grandaliano G., Gesualdo L., Bartoli F. et al. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int. 2000; 58 (1): 182-192.
  8. Viedt C., Dechend R., Fei J. et aL MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1. J. Am. Soc. Nephrol. 2002; 13 (6): 1534-1547.
  9. Mutter D. N., Dechend R., Mervaala E. et al. NF-kappaB inhibition ameliorates angiotensin П-induced inflammatory damage in rats. Hypertension 2000; 35 (1, pt 2): 193-201.
  10. Morrissey J., Klahr S. Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction. Semin. Nephrol. 1998; 18 (6): 603-611.
  11. Clayton A., Steadman R. ICAM-1 interactions in the renal interstitium: a novel activator of fibroblasts during nephritis. Histol. Histopathol. 1999; 14 (3): 861-870.
  12. Woolf A. S., Thiruchelvam N. Congenital obstructive uropathy: its origin and contribution to end-stage renal disease in children. Adv. Ren. Replace Ther. 2001; 8 (3): 157-163.
  13. Gerritsma J. S., Van Kooten C., Gerritsen A. et al. Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int. 1998; 53 (3): 609-616.
  14. Grandaliano G., Gesualdo L., Bartoli F. et al. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephrophathy. Kidney Int. 2000; 58 (1): 182-192.
  15. Stephan M., Conrad S., Eggert T. et al. Urinary concentration and tissue messenger mRNA expression of monocyte chemoattractant protein-1, as an indicator of the degree of hydronephrotic atrophy. J. Urol. (Baltimore) 2002; 167: 1497-1502.
  16. McDougal W. S., Kerr W. S. Jr. Obstructive uropathy. Curr. Opin. Urol. 1999; 9 (2): 107-109.
  17. Choi M. E. Mechanism of transforming growth factor-betal signaling. Kidney Int. 2000 (suppl.): S53-S58.
  18. Schnaper H. W., Hayashida Т., Hubchak S. C., Poncelet A. C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Renal Physiol. 2003; 284 (2): 243-252.
  19. Docherty N. G., Perez.-Barriocanal F, Balboa N. E., LopezNovoa J. M. Transforming growth factor-betal (TGF-betal): a potential recovery signal in the post-ischemic kidney. Ren. Fail. 2002; 24 (4): 391-406.
  20. Wolf G., Ziyadeh F. N., Stahl R. A. Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. J. Mol. Med. 1999; 77 (7): 556-564.
  21. Mezzano S. A., Ruiz-Ortega M., Egido J. Angiotensin II and renal fibrosis. Hypertension 2001; 38 (3, pt 2): 635-638.
  22. De Heer E., Sijpkens Y. W., Verkade M. et al. Morphometry of interstitial fibrosis. Nephrol. Dial. Transplant. 2000; 15 (suppl. 6): 72-73.
  23. Zeiberg M., Maeshima Y., Mosterman В., Katturi R. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am. J. Pathol. 2002; 160 (6): 2001-2008.
  24. Diez-Marques L., Ortega-Velazquez R., Langa С. et al. Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis. Biochim. Biophys. Acta 2002; 1587 (1): 36-44.
  25. Ledbetter S., Kurtzberg L., Doyle S., Pratt В. М. Renal fibrosis in mice trated with human recombinant transforming growth factor-beta2. Kidney Int. 2000; 58 (6): 2367-2376.
  26. Mozes M. M., Bottenger E. P., Jacot T. A. et al. Renal expression of fibrotic matrix proteins and transforming factor-beta isoforms in TGF-beta transgenic mice. J. Am. Soc. Nephrol. 1999; 10 (2): 271-280.
  27. Nabel E. G., Shum L., Pompili V. J. et al. Direct transfer transforming growth factor - beta 1 gene into arteries stimulates of fibrocellular hyperplasia. Proc. Natl. Acad. Sci. USA 1993; 90: 10759-10769.
  28. Saltis J., Agrotis A., Bobil A. Regulation and interaction of transforming growth factor - beta 1 with cardiovascular cells: Implications of development and disease. Clin. Exp. Pharmacol. Physiol. 1996; 23: 193-200.
  29. Kugler A. Matrix metalloproteinases and their inhibitors. Anticancer Res. 1999; 19 (2C): 1589-1592.
  30. Ina K., Kitamura H., Tatsukawa S. et al. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy. Med. Electron. Microsc. 2002; 35 (2): 87-95.
  31. Bmnton M. H., Kopp J. B. TGF-beta and fibrosis. Microbes Infect. 1999; 1 (15): 1349-1365.
  32. Kaneto H., Ohtani H., Fukuzaki A. et al. Increased expression of TGF-beta 1 but not of its receptors contributes to human obstructive nephropathy. Kidney Int. 1999; 56 (6): 2137-2146.
  33. Junker U., Haufe С. С., Nuske К. et al. Elevated plasma TGFbetal in renal diseases: cause or consequence? Cytokine 2000; 12 (7): 1084-1091.
  34. Chevalier R. L., Klahr S. Therapeutic approaches in obstructive uropathy. Semin. Nephrol. 1998; 18 (6): 652-658.
  35. Chevalier R. L. Effects of ureteral obstruction on renal growth. Semin. Nephrol. 1995; 15 (4): 353-360.
  36. Eddy A. A. Plasminogen activator inhibitor-1 and the kidnev. Am. J. Physiol. Renal Physiol. 2002; 283 (2): 209-220.
  37. Norman J. Т., Clark I. M., Garcia P. L. Hypoxia promotes fibrogenesis in human renal fibroblast. Kidney Int. 2000; 58 (6): 2351-2366.
  38. Sahai A., Mei C., Schrier R. W., Tannen R. L. Mechanisms of chronic hypoxia-induced renal cell growth. Kidney Int. 1999; 56 (4): 1277-1281.
  39. Wolf G. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms. Nephrologie 1998; 19 (7): 451-456.
  40. Mezzano S. A., Ruiz-Ortega M., Egido J. Angiotensin II and renal fibrosis. Hypertension 2001; 38 (3, pt 2): 635-638.
  41. Stroth U., Unger T. The renin-angiotensin system and its receptors. Cardiovasc. Pharmacol. 1999; 33 (1): 21-28.
  42. Zhuo J., Dean R., MacGregor D. et al. Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature. Clin. Exp. Pharmacol. Physiol. 1996; (3, suppl.): 147-154.
  43. Siragy H. M. AT(1) and AT(2) receptors in the kidney: role in disease and treatment. Am. J. Kidney Dis. 2000; 36 (3, suppl. 1): 4-9.
  44. Hohenfellner K., Hunley T. E., Yerkes E. et al. Angiotensin II, type 2 receptor in the development of vesico-ureteric reflux. ACE I/D gene polymorphism predicts renal damage in congenital uropathies. Br. J. Urol. Int. 1999; 83 (3): 318-322.
  45. Hohenfellner K., Hunley T. E., Schloemer С. et al. Angiotensin type 2 receptor is important in the normal development of the ureter. Pediatr. Nephrol. 1999; 13 (3): 187-191.
  46. Hayashi K., Matsuda H., Honda M., Saruta T. Potential role of angiotensin receptor antagonists in renal protection. Nippon Rinsho 1999; 57 (5): 1164-1167.
  47. Parvex P., Pippi-Salle J. L., Goodyer P. R. What role does apoptosis play in progression of renal disease? Pediatr. Nephrol. 2001; 16(12): 1076-1079.
  48. Makino H., Sugiyama H., Kashihara N. Apoptosis and extracellular matrix-cell interations in kidney disease. Kidney Int. 2000. 57 (suppl.): 67-75.
  49. Truong L. D., Sheikh-Hamad D., Chakraborty S. Cell Apoptosis and proliferation in obstructive uropathy. Semin. Nephrol. 1998; 18 (6): 641-661.
  50. Ortiz A., Justo P., Catalan M. P. et al. Apoptotic cell death in renal injury: the rationale for intervention. Curr. Drug Targets Immune Endocr. Metab. Disord. 2002; 2 (2): 181 - 192.
  51. Yang Y., Ji S., Wang С., Нои Y. Apoptosis of renal tubular cells in conginetal gydronefrosis. Chin. Med. J. 2001; 114 (5): 502- 505.
  52. Hegarty N. J., Watson R. W., Young L. S. et al. Cytoprotective effects of nitrates in a cellular model of hydronephrosis. Kidney Int. 2002; 62 (1): 70-77.
  53. Lama G., Ferraraccio F., Iaccarino F. et al. Pelviureteral junction obstruction: correlation of renal cell apoptosis and differential renal function. J. Urol. (Baltimore) 2003; 169 (6): 2335- 2358.
  54. Antus В., Mucsi I., Rosivall L. Apoptosis induction and inhibition of cellular prolifefation by angiotensin II: possible implication and perspectives. Acta Physiol. Hung. 2000; 87 (1): 5-24.
  55. Weidekamm C., Hauser P., Hansmann С. et al. Effects of ATI and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells. Wien. Klin. Wschr. 2002; 114 (15-16): 725-729.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies